Supplementary Tables 1-8 from Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER<sup>+</sup> Breast Cancer
<p>Suppl. Tables S1-S8</p>
Na minha lista:
| Autor principal: | Gary N. Schwartz (16005870) (author) |
|---|---|
| Outros Autores: | Peter A. Kaufman (16005873) (author), Karthik V. Giridhar (16005876) (author), Jonathan D. Marotti (16005879) (author), Mary D. Chamberlin (15036341) (author), Bradley A. Arrick (16005882) (author), Grace Makari-Judson (16005885) (author), Matthew P. Goetz (8863130) (author), Shannon M. Soucy (16005888) (author), Fred Kolling (16005891) (author), Eugene Demidenko (16005894) (author), Todd W. Miller (16005897) (author) |
| Publicado em: |
2025
|
| Assuntos: | |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Registos relacionados
-
Supplementary Figure 17 from Clinicopathologic, Genomic, and Immunophenotypic Landscape of <i>ATM</i> Mutations in Non–Small Cell Lung Cancer
Por: Biagio Ricciuti (14951247)
Publicado em: (2025) -
Supplementary Figure S1 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
Por: Arathi Mohan (15561346)
Publicado em: (2025) -
Supplementary Table S4 from Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04)
Por: Arathi Mohan (15561346)
Publicado em: (2025) -
Supplementary Figure 1 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Por: Tom Wei-Wu Chen (15053003)
Publicado em: (2025) -
Supplementary Figure 2 from A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma
Por: Tom Wei-Wu Chen (15053003)
Publicado em: (2025)